Literature DB >> 8826437

Genetic counseling of isolated carriers of Duchenne muscular dystrophy.

E P Hoffman1, E Pegoraro, P Scacheri, R G Burns, J W Taber, L Weiss, A Spiro, P Blattner.   

Abstract

It has recently become possible to detect female carriers of Duchenne muscular dystrophy with no affected male relative in the family. These "isolated carriers" represent about 10% of women with high serum creatine phosphokinase (CPK) levels and clinical evidence of a muscle disease. Most isolated carriers ascertained by clinical and/or CPK levels and diagnosed by dystrophin immunostaining of muscle biopsy show symptoms of a muscular dystrophy, and often carry the diagnosis of recessive "limb-girdle muscular dystrophy" prior to dystrophin analysis. It has been difficult to offer genetic counseling and prenatal diagnosis for Duchenne muscular dystrophy in the families of these isolated carriers, largely due to the difficulty in determining which of the dystrophin alleles segregating in the family harbors the mutation in the heterozygote. Here we report genetic counseling of three isolated carriers and their families. In two cases, prenatal diagnosis of at-risk pregnancies was conducted. We determined X inactivation patterns and inheritance of X chromosomes in each family, and used this information to define the at-risk dystrophin gene. In all three families, the mutation was a de novo event, two in the paternal germ-line, and one in the maternal germ-line. In each case we show that sibs of the heterozygous woman are at population risk, while pregnancies of each propositus are at high risk. Our results show that accurate genetic counseling and prenatal diagnosis can be offered to these families.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826437     DOI: 10.1002/(SICI)1096-8628(19960628)63:4<573::AID-AJMG11>3.0.CO;2-F

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28.

Authors:  E Pegoraro; J Whitaker; P Mowery-Rushton; U Surti; M Lanasa; E P Hoffman
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

2.  Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age.

Authors:  Sandra Mercier; Annick Toutain; Aurélie Toussaint; Martine Raynaud; Claire de Barace; Pascale Marcorelles; Laurent Pasquier; Martine Blayau; Caroline Espil; Philippe Parent; Hubert Journel; Leila Lazaro; Jon Andoni Urtizberea; Alexandre Moerman; Laurence Faivre; Bruno Eymard; Kim Maincent; Romain Gherardi; Denys Chaigne; Rabah Ben Yaou; France Leturcq; Jamel Chelly; Isabelle Desguerre
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

3.  Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth.

Authors:  Chunping Qiao; Juan Li; Hui Zheng; Janet Bogan; Jianbin Li; Zhenhua Yuan; Cheng Zhang; Dan Bogan; Joe Kornegay; Xiao Xiao
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

Review 4.  Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.

Authors:  Emanuela Viggiano; Manuela Ergoli; Esther Picillo; Luisa Politano
Journal:  Hum Genet       Date:  2016-04-21       Impact factor: 4.132

5.  The Classification, Natural History and Treatment of the Limb Girdle Muscular Dystrophies.

Authors:  Alexander Peter Murphy; Volker Straub
Journal:  J Neuromuscul Dis       Date:  2015-07-22

6.  Preimplantation genetic diagnosis associated to Duchenne muscular dystrophy.

Authors:  Bianca Bianco; Denise Maria Christofolini; Gabriel Seixas Conceição; Caio Parente Barbosa
Journal:  Einstein (Sao Paulo)       Date:  2017-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.